Related Experiment Video
Updated: Jan 26, 2026

Establishment of Viral Infection and Analysis of Host-Virus Interaction in Drosophila Melanogaster
Published on: March 14, 2019
The rabbit papillomavirus model: a valuable tool to study viral-host interactions
Nancy M Cladel1,2, Xuwen Peng3, Neil Christensen1,2,4
11 The Jake Gittlen Laboratories for Cancer Research, Pennsylvania State University College of Medicine , Hershey, PA 17033 , USA.
The Sylvilagus floridanus papillomavirus 1 (SfPV1)/rabbit model, initially Cottontail rabbit papillomavirus (CRPV), is crucial for understanding papillomavirus infections. This model aids in developing vaccines and antiviral therapies for human papillomavirus (HPV).
Area of Science:
- Virology
- Oncology
- Immunology
Background:
- Cottontail rabbit papillomavirus (CRPV), now Sylvilagus floridanus papillomavirus 1 (SfPV1), was the first tumorigenic DNA virus identified.
- The SfPV1/rabbit model serves as a vital preclinical tool for studying high-risk human papillomavirus (HPV) infections.
Purpose of the Study:
- To review the SfPV1/rabbit model's contributions to understanding viral pathogenesis, gene function, and host immune responses.
- To highlight the model's application in testing prophylactic and therapeutic HPV vaccines.
- To discuss its use in developing and validating novel antiviral and antitumor compounds.
Main Methods:
- Review of existing literature on the SfPV1/rabbit model.
- Discussion of applications in vaccine development (prophylactic and therapeutic).
- Exploration of the model's utility in preclinical testing of antiviral and antitumor agents.
Main Results:
- The SfPV1/rabbit model has been instrumental in the development of three successful prophylactic virus-like particle vaccines for HPV.
- The model facilitates in-depth study of viral-host interactions and immune responses.
- It is effective for evaluating novel therapeutic strategies against papillomavirus-induced diseases.
Conclusions:
- The SfPV1/rabbit model is indispensable for advancing knowledge of papillomavirus infections and diseases.
- Continued use of this model is essential for developing effective countermeasures against HPV.
- The model supports the validation of new antiviral and anticancer therapies.
More Related Videos
06:02Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors
Published on: September 13, 2018
07:35Double Labeling Immunofluorescence using Antibodies from the Same Species to Study Host-Pathogen Interactions
Published on: July 10, 2021
Related Concept Videos
Viral Structure
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Viral Recombination
Predator-Prey Interactions
Viral Mutations
Typical Model Studies